Jerrold D. Dotson's Insider Trades & SAST Disclosures
Jerrold D. Dotson's most recent trade in VistaGen Therapeutics Inc was a trade of 167 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on June 30, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jerrold D. Dotson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO | Grant, award, or other acquisition of securities at price $ 1.59 per share. | 30 Jun 2023 | 167 | 3,671 (0%) | 0% | 1.6 | 265 | Common Stock |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.09 per share. | 30 Dec 2022 | 5,000 | 105,111 (0%) | 0% | 0.1 | 438 | Common Stock |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.75 per share. | 30 Jun 2022 | 5,000 | 100,111 (0%) | 0% | 0.7 | 3,740 | Common Stock |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2022 | 18,750 | 15,625 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 11 Jan 2022 | 18,750 | 94,571 (0%) | 0% | 1 | 18,750 | Common Stock |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 30 Jun 2021 | 78,918 | 92,962 (0%) | 0% | 1 | 78,918 | Common Stock |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 78,918 | 34,375 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2021 | 36,707 | 113,293 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.40 per share. | 30 Jun 2021 | 9,824 | 102,786 (0%) | 0% | 0.4 | 3,910 | Common Stock |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 9,824 | 140,176 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 1.95 per share. | 30 Jun 2021 | 3,044 | 13,044 (0%) | 0% | 1.9 | 5,925 | Common Stock |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 30 Jun 2021 | 1,000 | 14,044 (0%) | 0% | 1.5 | 1,500 | Common Stock |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 1,000 | 0 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.45 per share. | 30 Jun 2020 | 5,000 | 5,000 (0%) | 0% | 0.4 | 2,240 | Common Stock |
| VistaGen Therapeutics Inc | Jerrold D. Dotson | VP, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges